This paper is only available as a PDF. To read, Please Download here.
Abstract
This paper provides an overview of the use of pharmacoeconomic analysis in the process
that governs drug reimbursement decisions in Australia. It discusses the methods by
which drugs are evaluated, both clinically and economically, and the means by which
these 2 facets are amalgamated; the types of pharmacoeconomic data submitted in support
of requests for reimbursement; the methods and standards used to assess these data;
some of the more commonly encountered flaws in the data submitted; and how the different
types of data influence reimbursement decisions.
Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical TherapeuticsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee.Australian Government Publishing Service, 1995
- Equivalence trials.NEJM. 1997; 337: 1159-1161
- An empirical study of the ef-fect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials.Stat Med. 1998; 17: 1923-1942
- 2nd ed. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, Oxford, England1997: 6-26
Article info
Publication history
Accepted:
April 21,
1999
Footnotes
**This article is based on Dr. Henry's presentation at the 99th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, which was held March 30 to April 1, 1998, in New Orleans, Louisiana. The article has been updated to include subsequent developments.
Identification
Copyright
© 1999 Published by Elsevier Inc.
